This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Soltani, M. H. Articles by Setaluri, V. Search for Related Content PubMed PubMed Citation Articles by Soltani, M. H. Articles by Setaluri, V.

(American Journal of Pathology. 2005;166:1841-1850.)
© 2005 American Society for Investigative Pathology

Microtubule-Associated Protein 2, a Marker of Neuronal Differentiation, Induces Mitotic Defects, Inhibits Growth of Melanoma Cells, and Predicts Metastatic Potential of Cutaneous Melanoma

Mohammad H. Soltani^*, Rita Pichardo, Ziqui Song, Namrata Sangha, Fabian Camacho, Kapaettu Satyamoorthy^¶, Omar P. Sangueza and Vijayasaradhi Setaluri^*

From the Departments of Cancer Biology,^* Pathology, Dermatology, and Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina; and the Wistar Institute,^¶ Philadelphia, Pennsylvania

Dynamic instability of microtubules is critical for mitotic spindle assembly and disassembly during cell division, especially in rapidly dividing tumor cells. Microtubule-associated proteins (MAPs) are a family of proteins that influence this property. We showed previously that MAP2, a neuron-specific protein that stabilizes microtubules in the dendrites of postmitotic neurons, is induced in primary cutaneous melanoma but is absent in metastatic melanomas. We proposed that induction of a microtubule-stabilizing protein in primary melanoma could disrupt the dynamic instability of microtubules, inhibit cell division and prevent or delay tumor progression. Here we show, by Kaplan-Meier survival and multivariate Cox regression analysis, that patients diagnosed with MAP2⁺ primary melanomas have significantly better metastatic disease-free survival than those with MAP2^– disease. Investigation of the mechanisms that underlie the effect of MAP2 on melanoma progression showed that MAP2 expression in metastatic melanoma cell lines leads to microtubule stabilization, cell cycle arrest in G2-M phase and growth inhibition. Disruption of microtubule dynamics by MAP2 resulted in multipolar mitotic spindles, defects in cytokinesis and accumulation of cells with large nuclei, similar to those seen in vivo in MAP2⁺ primary melanomas cells. These data suggest that ectopic activation of a neuronal differentiation gene in melanoma during early tumor progression inhibits cell division and correlates with inhibition or delay of metastasis.

This article has been cited by other articles:

				B. Belletti, M. S. Nicoloso, M. Schiappacassi, S. Berton, F. Lovat, K. Wolf, V. Canzonieri, S. D'Andrea, A. Zucchetto, P. Friedl, et al. Stathmin Activity Influences Sarcoma Cell Shape, Motility, and Metastatic Potential Mol. Biol. Cell, May 1, 2008; 19(5): 2003 - 2013. [Abstract] [Full Text] [PDF]

				K. M.R. Bhat and V. Setaluri Microtubule-Associated Proteins as Targets in Cancer Chemotherapy Clin. Cancer Res., May 15, 2007; 13(10): 2849 - 2854. [Abstract] [Full Text] [PDF]

				V. Bolos, J. Grego-Bessa, and J. L. de la Pompa Notch Signaling in Development and Cancer Endocr. Rev., May 1, 2007; 28(3): 339 - 363. [Abstract] [Full Text] [PDF]

				K. M. R. Bhat, N. Maddodi, C. Shashikant, and V. Setaluri Transcriptional regulation of human MAP2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling Nucleic Acids Res., August 11, 2006; 34(13): 3819 - 3832. [Abstract] [Full Text] [PDF]